Intraoperative high-dose-rate brachytherapy: An American Brachytherapy Society consensus report

S Lloyd1, K M Alektiar2, S Nag3

  • 1Huntsman Cancer Institute, Department of Radiation Oncology, University of Utah, Salt Lake City, UT.

Brachytherapy
|February 9, 2017
PubMed
Summary

The American Brachytherapy Society recommends intraoperative high-dose-rate (IOHDR) brachytherapy for specific cancers, particularly those with close margins or recurrence. This guide details IOHDR treatment planning and delivery for improved cancer control.